Ramosetron

Ramosetron

Systematic (IUPAC) name
(1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]methanone
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Intravenous
Pharmacokinetic data
Biological half-life	5.8 hours
Identifiers
CAS Number	132907-72-3 Y
ATC code	none
PubChem	CID: 108000
IUPHAR/BPS	2301
ChemSpider	97112 N
UNII	7ZRO0SC54Y N
ChEMBL	CHEMBL1643895 N
Chemical data
Formula	C17H17N3O
Molecular mass	279.33 g/mol
SMILES CN1C=C(C2=CC=CC=C21)C(=O)[C@@H]3CCC4=C(C3)NC=N4
InChI InChI=1S/C17H17N3O/c1-20-9-13(12-4-2-3-5-16(12)20)17(21)11-6-7-14-15(8-11)19-10-18-14/h2-5,9-11H,6-8H2,1H3,(H,18,19)/t11-/m1/s1 N Key:NTHPAPBPFQJABD-LLVKDONJSA-N N
NY (what is this?)  (verify)

Ramosetron (INN) is a serotonin 5-HT₃ receptor antagonist for the treatment of nausea and vomiting. Ramosetron is also indicated for a treatment of “diarrhea-predominant irritable bowel syndrome in males”. In India it is marketed under the brand name of "IBset".

It is only licensed for use in Japan and selected Southeast Asian countries.　In Japan it is sold under the tradename Iribo (イリボー). Elsewhere it is commonly sold under the tradename Nasea and in India as Nozia (300 mcg/ml Inj. & 100 mcg Tab.)